FSM Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
11,630
+765
+7% +$178K 0.31% 46
2026
Q1
$2.66M Sell
10,865
-394
-3% -$91.8K 0.34% 43
2025
Q4
$2.33M Buy
11,259
+1,243
+12% +$246K 0.32% 47
2025
Q3
$1.86M Buy
10,016
+1,563
+18% +$268K 0.26% 58
2025
Q2
$1.31M Buy
8,453
+4,378
+107% +$673K 0.21% 69
2025
Q1
$676K Buy
4,075
+1,080
+36% +$169K 0.15% 86
2024
Q4
$443K Sell
2,995
-134
-4% -$20.8K 0.11% 104
2024
Q3
$507K Sell
3,129
-208
-6% -$33.1K 0.13% 93
2024
Q2
$488K Sell
3,337
-159
-5% -$23.6K 0.16% 85
2024
Q1
$553K Sell
3,496
-250
-7% -$39.8K 0.2% 81
2023
Q4
$587K Sell
3,746
-72
-2% -$11K 0.25% 71
2023
Q3
$595K Sell
3,818
-457
-11% -$75.4K 0.3% 68
2023
Q2
$678K Sell
4,275
-220
-5% -$35.5K 0.34% 63
2023
Q1
$697K Buy
4,495
+362
+9% +$58.5K 0.4% 60
2022
Q4
$730K Sell
4,133
-573
-12% -$98.9K 0.52% 48
2022
Q3
$769K Buy
4,706
+742
+19% +$126K 0.64% 44
2022
Q2
$675K Buy
+3,964
New +$706K 0.67% 39

Other funds holding JNJ

FSM Wealth Advisors's JNJ Position: Q2 2026 in Review

FSM Wealth Advisors increased its Johnson & Johnson (JNJ) stake by 7% in Q2 2026, buying an estimated $178K and bringing the position to 11,630 shares worth $2.95M. The position accounts for 0.31% of the portfolio, ranked #46.

FSM Wealth Advisors first reported a position in JNJ in Q2 2022 and has held it in 17 quarters since. 2,719 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • FSM Wealth Advisors held 11,630 shares of Johnson & Johnson worth $2.95M as of Q2 2026.
  • FSM Wealth Advisors bought 765 Johnson & Johnson shares in Q2 2026, an estimated $178K.
  • Johnson & Johnson made up 0.31% of FSM Wealth Advisors's portfolio in Q2 2026, its #46 holding.
  • FSM Wealth Advisors first reported a position in Johnson & Johnson in Q2 2022 and has held it in 17 quarters since.
  • 2,719 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.